DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $18.85 which represents a slight increase of $0.24 or 1.29% from the prior close of $18.61. The stock opened at $18.51 and ...
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...
CHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43 rd Annual J.P.
In a report released today, Allen Lutz from Bank of America Securities maintained a Hold rating on DENTSPLY SIRONA (XRAY – Research Report).
Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, ...
THE LAWSUIT: A class action securities lawsuit was filed against Dentsply Sirona Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 6 ...
Prior to the start of the Class Period, on December 21, 2020, Dentsply paid $1.04 billion in cash to acquire Byte, a manufacturer of affordable, “doctor-directed,” direct-to-consumer (“DTC ...
Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...
DENTSPLY SIRONA Inc. CHARLOTTE, N.C., Dec. 13, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive ...
NDAQ:XRAY) ROSEN, A LEADING LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRAY ...